Uniphar plc (FRA:0NR)

Market Cap	1.05B +55.5%
Revenue (ttm)	2.89B +7.7%
Net Income	66.31M +46.8%
EPS	0.25 +49.6%
Shares Out	n/a
PE Ratio	15.82
Forward PE	16.56
Dividend	0.02 (0.49%)
Ex-Dividend Date	Sep 11, 2025

Volume	n/a
Average Volume	2,237
Open	4.010
Previous Close	4.000
Day's Range	3.990 - 4.010
52-Week Range	2.235 - 4.165
Beta	n/a
RSI	61.41
Earnings Date	Feb 24, 2026

About Uniphar

Uniphar plc, together with its subsidiaries, operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, the Netherlands, and internationally. It operates through three divisions: Uniphar Medtech, Uniphar Pharma, and Uniphar Supply Chain & Retail. The company provides sales, marketing, compliance, and distribution services to medical device manufacturers; high-value services across the life cycle of a pharmaceutical product; and healthcare professionals with access to medicines that cannot source throug...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1967
• Employees: 3,500
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 0NR

Financial Performance

In 2024, Uniphar's revenue was 2.77 billion, an increase of 8.51% compared to the previous year's 2.55 billion. Earnings were 64.20 million, an increase of 43.26%.